by GlobeNewsWire | Jun 13, 2016 | Feature Box, Featured, FP, Globe Newswire
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment...
by GlobeNewsWire | Apr 18, 2016 | Globe Newswire
– Phase I/II Clinical Trial to Begin in Second Quarter of 2016 – EXTON, Pa. and GERMANTOWN, Md., April 18, 2016 (GLOBE NEWSWIRE) — Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing...
by GlobeNewsWire | Mar 23, 2016 | Globe Newswire
NEW YORK, March 23, 2016 (GLOBE NEWSWIRE) — The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Freeport-McMoRan Inc. (“Freeport-McMoRan”) (NYSE:FCX) between February...
by GlobeNewsWire | Mar 10, 2016 | Globe Newswire
EXTON, Pa., March 10, 2016 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting the skin, connective tissue and joints, today reported...
by GlobeNewsWire | Feb 8, 2016 | Globe Newswire, GNW Alerts
STEVENSON, Md., Feb. 08, 2016 (GLOBE NEWSWIRE) — The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of...
